|
Animal models of human disease
Citations 301-310 of 1389 total displayed.
|
Past content
(since Jan 1999):
|
- Scientific Contributions
Effects of Aliskiren on Blood Pressure, Albuminuria, and (Pro)Renin Receptor Expression in Diabetic TG(mREN-2)27 Rats
- David L. Feldman, Liang Jin, Hong Xuan, Aurelie Contrepas, Yinong Zhou, Randy L. Webb, Dominik N. Mueller, Sandra Feldt, Frederick Cumin, Wieslawa Maniara, Elke Persohn, Helmut Schuetz, A. H. Jan Danser, and Genevieve Nguyen
Hypertension published May 19, 2008, doi:10.1161/HYPERTENSIONAHA.107.108845
[Abstract]
- Scientific Contributions
Postnatal Intermittent Hypoxia and Developmental Programming of Hypertension in Spontaneously Hypertensive Rats. The Role of Reactive Oxygen Species and L-Ca2+ Channels
- Galia K. Soukhova-O'Hare, Roger V. Ortines, Yan Gu, Alexander D. Nozdrachev, Sumanth D. Prabhu, and David Gozal
Hypertension published May 12, 2008, doi:10.1161/HYPERTENSIONAHA.108.110296
[Abstract]
- Brief Reviews
Developmental Programming of Hypertension. Insight From Animal Models of Nutritional Manipulation
- Norma B. Ojeda, Daniela Grigore, and Barbara T. Alexander
Hypertension published May 12, 2008, doi:10.1161/HYPERTENSIONAHA.107.092890
[Abstract]
- Hypertension Highlights
Angiotensin II-Dependent Superoxide. Effects on Hypertension and Vascular Dysfunction
- William J. Welch
Hypertension published May 12, 2008, doi:10.1161/HYPERTENSIONAHA.107.090472
[Abstract]
- Brief Reviews
Critical Review of Prorenin and (Pro)renin Receptor Research
- Duncan J. Campbell
Hypertension 2008;51:1259-1264; published online before print as doi:10.1161/HYPERTENSIONAHA.108.110924
[Full text]
- Original Articles
Renin Inhibition by Aliskiren Prevents Atherosclerosis Progression: Comparison With Irbesartan, Atenolol, and Amlodipine
- Jürg Nussberger, Jean-François Aubert, Karima Bouzourene, Maxime Pellegrin, Daniel Hayoz, and Lucia Mazzolai
Hypertension 2008;51:1306-1311; published online before print as doi:10.1161/HYPERTENSIONAHA.108.110932
[Abstract]
[Full text]
- Original Articles
Orally Active Aminopeptidase A Inhibitors Reduce Blood Pressure: A New Strategy for Treating Hypertension
- Laurence Bodineau, Alain Frugière, Yannick Marc, Nicolas Inguimbert, Céline Fassot, Fabrice Balavoine, Bernard Roques, and Catherine Llorens-Cortes
Hypertension 2008;51:1318-1325; published online before print as doi:10.1161/HYPERTENSIONAHA.107.098772
[Abstract]
[Full text]
- Original Articles
Involvement of Tumor Necrosis Factor- in Angiotensin II–Mediated Effects on Salt Appetite, Hypertension, and Cardiac Hypertrophy
- Srinivas Sriramula, Masudul Haque, Dewan S.A. Majid, and Joseph Francis
Hypertension 2008;51:1345-1351; published online before print as doi:10.1161/HYPERTENSIONAHA.107.102152
[Abstract]
[Full text]
- Original Articles
Salutary Effect of Kallistatin in Salt-Induced Renal Injury, Inflammation, and Fibrosis via Antioxidative Stress
- Bo Shen, Makoto Hagiwara, Yu-Yu Yao, Lee Chao, and Julie Chao
Hypertension 2008;51:1358-1365; published online before print as doi:10.1161/HYPERTENSIONAHA.107.108514
[Abstract]
[Full text]
- Original Articles
Nitric Oxide Deficiency and Increased Adenosine Response of Afferent Arterioles in Hydronephrotic Mice With Hypertension
- Mattias Carlström, En Yin Lai, Andreas Steege, Mauricio Sendeski, Zufu Ma, Sheller Zabihi, Ulf J. Eriksson, Andreas Patzak, and A. Erik G. Persson
Hypertension 2008;51:1386-1392; published online before print as doi:10.1161/HYPERTENSIONAHA.108.111070
[Abstract]
[Full text]
|
|